HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ashok K Chopra Selected Research

Plague (Bubonic Plague)

12/2021Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
6/2021Plague vaccines: new developments in an ongoing search.
1/2021A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.
1/2019A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells.
10/2018A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
1/2018Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.
1/2017Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.
1/2016New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.
1/2016A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
12/2015Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ashok K Chopra Research Topics

Disease

27Infections
01/2021 - 10/2005
23Plague (Bubonic Plague)
12/2021 - 04/2008
9Anthrax
10/2018 - 12/2005
7Inflammation (Inflammations)
06/2010 - 02/2002
7Edema (Dropsy)
01/2010 - 12/2005
4Inhalation anthrax
01/2017 - 02/2006
3Virus Diseases (Viral Diseases)
09/2021 - 12/2004
3Clostridium Infections
10/2020 - 01/2016
2Body Weight (Weight, Body)
11/2011 - 02/2006
2Respiratory Tract Infections (Respiratory Tract Infection)
11/2011 - 06/2010
2Septic Shock (Toxic Shock Syndrome)
01/2010 - 01/2010
2Neoplasms (Cancer)
07/2009 - 04/2007
1COVID-19
06/2021
1Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
10/2020
1Coinfection
11/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Leukoencephalopathies
01/2017
1Typhoid Fever (Typhoid)
01/2017
1Shock
11/2014
1Necrotizing Fasciitis
07/2014
1Wound Infection (Wound Infections)
04/2013
1Whooping Cough (Pertussis)
10/2012
1Cholera
10/2012
1Diphtheria
10/2012
1Diarrhea
10/2012

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
12/2021 - 04/2007
9Lipoproteins (Lipoprotein)IBA
12/2015 - 04/2008
8CytokinesIBA
01/2021 - 12/2005
7AntigensIBA
10/2018 - 12/2004
7Levofloxacin (Levaquin)FDA Link
01/2018 - 04/2008
6Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 02/2006
6Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2007
6Virulence Factors (Pathogenicity Factors)IBA
01/2017 - 01/2006
5EnzymesIBA
01/2017 - 10/2005
5Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2010 - 12/2005
4Pharmaceutical PreparationsIBA
10/2020 - 07/2009
4ChemokinesIBA
06/2011 - 11/2006
3Attenuated VaccinesIBA
12/2021 - 06/2014
3Amoxapine (Asendin)FDA Link
10/2020 - 01/2016
3Trifluoperazine (Stelazine)FDA LinkGeneric
10/2020 - 01/2016
3Doxapram (Doxapram Hydrochloride)FDA LinkGeneric
10/2020 - 01/2016
3Type VI Secretion SystemsIBA
01/2017 - 12/2010
3phospholipase A2-activating proteinIBA
01/2017 - 02/2002
3Adenosine Triphosphate (ATP)IBA
01/2017 - 08/2006
3Enterotoxins (Enterotoxin)IBA
04/2013 - 01/2006
3Type III Secretion SystemsIBA
04/2013 - 05/2006
3Ciprofloxacin (Cipro)FDA LinkGeneric
06/2010 - 02/2006
2Immunoglobulin G (IgG)IBA
09/2021 - 01/2021
2Virus ReceptorsIBA
09/2021 - 01/2021
2Antidepressive Agents (Antidepressants)IBA
10/2020 - 01/2018
2Antipsychotic Agents (Antipsychotics)IBA
10/2020 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 09/2013
2Plague VaccineIBA
10/2018 - 01/2017
2AntibodiesIBA
01/2017 - 02/2013
2Carrier Proteins (Binding Protein)IBA
01/2017 - 05/2015
2ImmunosorbentsIBA
01/2017 - 02/2006
2AcyltransferasesIBA
12/2015 - 03/2013
2LipopolysaccharidesIBA
03/2013 - 11/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2010 - 02/2002
2Peptidoglycan (Murein)IBA
01/2010 - 10/2009
2Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2009 - 12/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008 - 02/2002
2AVP-21D9IBA
07/2007 - 02/2006
2Peptides (Polypeptides)IBA
04/2007 - 12/2004
1Chemotactic FactorsIBA
01/2021
1Interleukin-33IBA
10/2020
1Antimalarials (Antimalarial Agents)IBA
07/2019
1Subunit VaccinesIBA
10/2018
1BiothraxIBA
10/2018
1Biological Warfare AgentsIBA
10/2018
1Capsid Proteins (Capsid Protein)IBA
10/2018
1NanovaccinesIBA
10/2018
1Combined VaccinesIBA
10/2018
1VancomycinFDA LinkGeneric
01/2018
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2017
1Dinoprostone (PGE2)FDA Link
01/2017
1Ribose (D-Ribose)IBA
01/2017
1SugarsIBA
05/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2015
1AcidsIBA
11/2014
1PlasminogenIBA
06/2014
1Peptide Hydrolases (Proteases)FDA Link
06/2014
1Histones (Histone)IBA
09/2013
1Hemolysin Proteins (Hemolysins)IBA
04/2013
1ExotoxinsIBA
04/2013
1lauric acid (dodecanoic acid)IBA
03/2013
1Lipid AIBA
03/2013
1Recombinant ProteinsIBA
02/2013
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2013
1ADP Ribose Transferases (ADP Ribosyltransferase)IBA
10/2012
1bis(3',5')-cyclic diguanylic acidIBA
09/2012
1Guanosine Monophosphate (5' Guanylic Acid)IBA
09/2012
1Glucose (Dextrose)FDA LinkGeneric
06/2012
1Synthetic Vaccines (Recombinant Vaccines)IBA
06/2012
1Bacterial Proteins (Bacterial Protein)IBA
11/2011
1cethromycinIBA
11/2011
1DNA GyraseIBA
11/2011
1Acyl-ButyrolactonesIBA
07/2011

Therapy/Procedure

6Therapeutics
10/2020 - 02/2006
1Intramuscular Injections
11/2019